Home › Melanoma › New Jersey › Camden
Melanoma clinical trials in Camden, NJ
4 studies for Melanoma are looking for participants at sites in and around Camden (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- MD Anderson Cancer Center at Cooper, Camden
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Inspira Medical Center Mullica Hill, Mullica Hill · 14 mi away
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RecruitingPhase 3
- MD Anderson Cancer Center at Cooper, Camden
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
RecruitingPhase 2
- Cooper Hospital UNIV MED CTR., Camden
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX61 studies
- New York City, NY41 studies
- Nashville, TN34 studies
- Los Angeles, CA34 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- St. Louis, MO23 studies
- Durham, NC22 studies
- Philadelphia, PA22 studies
- Tampa, FL21 studies
- Columbus, OH21 studies
- Dallas, TX21 studies
Other studies in Camden
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer10 studies
- Schizophrenia9 studies
- Heart Failure8 studies
- Breast Cancer7 studies
- Cancer (all types)7 studies
- Coronary Artery Disease7 studies
- Ovarian Cancer6 studies
- COPD6 studies
- Major Depressive Disorder6 studies
- Cardiovascular Disease6 studies
- High Blood Pressure5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.